# Tailored Therapy for Helicobacter Pylori in Children

> **NCT02635191** · PHASE4 · UNKNOWN · sponsor: **Beijing Children's Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Tailored Group
- **DRUG:** Standard group

## Key facts

- **NCT ID:** NCT02635191
- **Lead sponsor:** Beijing Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-03
- **Final completion:** 2016-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2015-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02635191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02635191, "Tailored Therapy for Helicobacter Pylori in Children". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02635191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*